Start for free

JB Chemicals & Pharmaceuticals Limited

NSE: JBCHEPHARMHealthcare

JB Chemicals & Pharmaceuticals Limited Share Price & Analysis

₹2416.10+0.30%Updated 25 Aug 2026, 05:02 pm IST
LTP
₹2416.10+0.30%
Open
—
High
₹2525.50
Low
₹2380.00
Close
₹2416.10
52W High
₹2526.00
52W Low
₹1603.00
Volume
4779K
Lot Size
1
Sector
Healthcare
Market Cap
₹39K Cr
Face Value
₹1
Large CapNIFTY 500

Price Chart

Candle
Range

Fundamentals

P/E
53.80
Sector P/E
54.70
P/B
8.22
EPS
₹44.52
ROE
18.90%
ROCE
25.40%
D/E Ratio
0.00
Div Yield
0.91%
Book Value
₹259.00

Strengths

  • Strong return on equity (ROE 18.9%)
  • Efficient capital deployment (ROCE 25.4%)
  • Virtually debt-free

Concerns

  • High premium to book value (P/B 8.2x)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,899
₹4.6L Cr36.15.461620.50.07
DIVISLAB
Divi's Laboratories Limited
₹9,100
₹2.4L Cr81.114.4216.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
₹4,857
₹1.8L Cr82.819.5827.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹8,650
₹1.2L Cr59.113.1321.217.40.88
CIPLA
Cipla Limited
₹1,385
₹1.1L Cr31.33.2511.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
₹1,120
₹1.1L Cr234.1621.221.10.38
LAURUSLABS
Laurus Labs Limited
₹1,840
₹99K Cr90.918.7418.317.80.46

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

JBCHEPHARM · as of Mar 2026

Promoters47.84%5.82pp
FII18.30%3.66pp
DII18.71%2.31pp
Public15.13%0.16pp
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters53.83%53.78%53.77%53.74%53.66%47.84%
FII10.35%11.06%12.17%13.63%14.64%18.30%
DII18.53%18.38%17.61%16.81%16.40%18.71%
Public17.27%16.78%16.42%15.80%15.29%15.13%
Govt—0.01%—0.01%——

Corporate Events

Merger

Event16 Jul 2026

Dividend - Rs 9.30 Per Share

Dividend28 May 2026

Interim Dividend - Rs 12.70 Per Share

Dividend10 Feb 2026

Dividend - Rs 7 Per Share

Dividend29 Jul 2025

Interim Dividend - Rs 8.50 Per Share

Record: 7 Feb 2025

Dividend6 Feb 2025

Dividend - Rs 6.75 Per Share

Dividend13 Aug 2024

Interim Dividend - Rs 5.50 Per Share

Dividend15 Feb 2024

Face Value Split (Sub-Division) - From Rs 2/- Per Share To Re 1/- Per Share

Split17 Sept 2023

Dividend - Rs 9.25 Per Share

Dividend16 Aug 2023

Latest News

All news

JB Chemicals shares unchanged after general updates filing

*JB Chemicals shares unchanged after general updates filing*\nJB Chemicals & Pharmaceuticals informed the NSE about routine corporate updates. No specific financial or operational details were disclosed. The filing appears to be procedural with no immediate market-moving information.\n\n📊 *STOCKS:* JBCHHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #corporate_update

NSE Filing8 Jul
Low Impact

Financials

Quarterly Results

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
₹904 Cr
15.1%
₹1.1K Cr
1.8%
₹1.1K Cr
0.8%
₹1.1K Cr
15.3%
₹949 Cr
1.5%
₹963 Cr
3.8%
₹1.0K Cr
0.3%
₹1.0K Cr
Op. Profit
₹201 Cr
32.1%
₹296 Cr
4.5%
₹310 Cr
3.0%
₹301 Cr
33.2%
₹226 Cr
11.4%
₹255 Cr
5.9%
₹271 Cr
3.2%
₹280 Cr
OPM
22.0%
21.4%
28.0%
3.4%
29.0%
3.6%
28.0%
16.7%
24.0%
7.7%
26.0%
3.7%
27.0%
3.6%
28.0%
Net Profit
₹101 Cr
49.0%
₹198 Cr
4.8%
₹208 Cr
3.0%
₹202 Cr
38.4%
₹146 Cr
9.9%
₹162 Cr
7.4%
₹175 Cr
1.1%
₹177 Cr
EPS (₹)
6.31
50.0%
12.63
4.8%
13.27
2.4%
12.96
38.5%
9.36
10.4%
10.45
7.0%
11.24
1.3%
11.39

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Revenue
₹4.1K Cr
5.9%
₹3.9K Cr
12.5%
₹3.5K Cr
10.6%
₹3.1K Cr
29.9%
₹2.4K Cr
18.6%
₹2.0K Cr
15.1%
₹1.8K Cr
8.0%
₹1.6K Cr
16.7%
₹1.4K Cr
4.8%
₹1.3K Cr
Expenses
₹3.0K Cr
5.3%
₹2.9K Cr
11.6%
₹2.6K Cr
5.4%
₹2.5K Cr
30.5%
₹1.9K Cr
26.9%
₹1.5K Cr
6.1%
₹1.4K Cr
4.5%
₹1.3K Cr
12.3%
₹1.2K Cr
7.1%
₹1.1K Cr
Op. Profit
₹1.1K Cr
7.3%
₹1.0K Cr
15.1%
₹897 Cr
28.9%
₹696 Cr
28.2%
₹543 Cr
3.0%
₹560 Cr
48.1%
₹378 Cr
23.5%
₹306 Cr
40.4%
₹218 Cr
6.0%
₹232 Cr
OPM
27.0%
3.8%
26.0%
0.0%
26.0%
18.2%
22.0%
0.0%
22.0%
18.5%
27.0%
28.6%
21.0%
10.5%
19.0%
26.7%
15.0%
11.8%
17.0%
Other Income
₹33 Cr
13.2%
₹38 Cr
2.7%
₹37 Cr
270.0%
₹10 Cr
74.4%
₹39 Cr
65.2%
₹112 Cr
173.2%
₹41 Cr
0.0%
₹41 Cr
10.8%
₹37 Cr
26.0%
₹50 Cr
Interest
₹6 Cr
50.0%
₹12 Cr
72.7%
₹44 Cr
22.2%
₹36 Cr
620.0%
₹5 Cr
28.6%
₹7 Cr
133.3%
₹3 Cr
40.0%
₹5 Cr
66.7%
₹3 Cr
40.0%
₹5 Cr
Depreciation
₹182 Cr
6.4%
₹171 Cr
23.9%
₹138 Cr
21.1%
₹114 Cr
56.2%
₹73 Cr
5.8%
₹69 Cr
4.5%
₹66 Cr
17.9%
₹56 Cr
1.8%
₹57 Cr
21.3%
₹47 Cr
PBT
₹952 Cr
7.3%
₹887 Cr
18.0%
₹752 Cr
35.5%
₹555 Cr
9.9%
₹505 Cr
15.4%
₹597 Cr
71.1%
₹349 Cr
21.6%
₹287 Cr
47.9%
₹194 Cr
15.7%
₹230 Cr
Tax %
26.0%
0.0%
26.0%
0.0%
26.0%
0.0%
26.0%
8.3%
24.0%
4.0%
25.0%
13.6%
22.0%
31.3%
32.0%
14.3%
28.0%
40.0%
20.0%
Net Profit
₹709 Cr
7.4%
₹660 Cr
19.3%
₹553 Cr
34.9%
₹410 Cr
6.2%
₹386 Cr
14.0%
₹449 Cr
65.1%
₹272 Cr
40.2%
₹194 Cr
39.6%
₹139 Cr
24.5%
₹184 Cr
EPS (₹)
44.18
4.3%
42.36
19.0%
35.61
34.5%
26.48
6.2%
24.93
14.0%
28.98
64.7%
17.6
45.9%
12.06
45.8%
8.27
23.8%
10.85
Div Payout
50.0%
35.1%
37.0%
8.8%
34.0%
0.0%
34.0%
3.0%
33.0%
17.9%
28.0%
9.7%
31.0%
47.6%
21.0%
75.0%
12.0%
140.0%
5.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Liabilities
Equity Capital
₹16 Cr
0.0%
₹16 Cr
0.0%
₹16 Cr
6.7%
₹15 Cr
0.0%
₹15 Cr
0.0%
₹15 Cr
0.0%
₹15 Cr
6.3%
₹16 Cr
5.9%
₹17 Cr
0.0%
₹17 Cr
Reserves
₹4.1K Cr
21.2%
₹3.4K Cr
17.5%
₹2.9K Cr
18.0%
₹2.5K Cr
16.3%
₹2.1K Cr
18.1%
₹1.8K Cr
26.3%
₹1.4K Cr
3.0%
₹1.5K Cr
2.7%
₹1.4K Cr
5.8%
₹1.3K Cr
Borrowings
₹4 Cr
85.7%
₹28 Cr
92.6%
₹378 Cr
33.9%
₹572 Cr
940.0%
₹55 Cr
22.2%
₹45 Cr
55.2%
₹29 Cr
11.5%
₹26 Cr
10.3%
₹29 Cr
40.8%
₹49 Cr
Other Liabilities
₹799 Cr
0.6%
₹804 Cr
17.0%
₹687 Cr
38.8%
₹495 Cr
20.1%
₹412 Cr
9.6%
₹376 Cr
7.7%
₹349 Cr
22.0%
₹286 Cr
2.7%
₹294 Cr
12.2%
₹262 Cr
Total Liabilities
₹5.0K Cr
16.3%
₹4.3K Cr
6.9%
₹4.0K Cr
12.4%
₹3.5K Cr
36.4%
₹2.6K Cr
16.6%
₹2.2K Cr
23.0%
₹1.8K Cr
1.2%
₹1.8K Cr
1.5%
₹1.8K Cr
5.4%
₹1.7K Cr
Assets
Fixed Assets
₹1.9K Cr
4.2%
₹2.0K Cr
1.8%
₹2.0K Cr
5.4%
₹1.9K Cr
48.9%
₹1.3K Cr
101.4%
₹634 Cr
2.6%
₹651 Cr
4.8%
₹621 Cr
3.0%
₹640 Cr
5.7%
₹679 Cr
CWIP
₹74 Cr
17.5%
₹63 Cr
17.1%
₹76 Cr
38.2%
₹55 Cr
189.5%
₹19 Cr
26.9%
₹26 Cr
62.5%
₹16 Cr
6.7%
₹15 Cr
11.8%
₹17 Cr
325.0%
₹4 Cr
Investments
₹765 Cr
121.7%
₹345 Cr
11.1%
₹388 Cr
88.3%
₹206 Cr
1484.6%
₹13 Cr
98.1%
₹678 Cr
68.2%
₹403 Cr
11.8%
₹457 Cr
5.3%
₹434 Cr
5.6%
₹411 Cr
Other Assets
₹2.2K Cr
18.4%
₹1.9K Cr
24.4%
₹1.5K Cr
9.7%
₹1.4K Cr
7.1%
₹1.3K Cr
44.6%
₹894 Cr
20.3%
₹743 Cr
6.3%
₹699 Cr
3.7%
₹674 Cr
16.2%
₹580 Cr
Total Assets
₹5.0K Cr
16.3%
₹4.3K Cr
6.9%
₹4.0K Cr
12.4%
₹3.5K Cr
36.4%
₹2.6K Cr
16.6%
₹2.2K Cr
23.0%
₹1.8K Cr
1.2%
₹1.8K Cr
1.5%
₹1.8K Cr
5.4%
₹1.7K Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Operating CF
₹704 Cr
22.0%
₹902 Cr
12.6%
₹801 Cr
28.0%
₹626 Cr
268.2%
₹170 Cr
46.0%
₹315 Cr
14.1%
₹276 Cr
42.3%
₹194 Cr
57.7%
₹123 Cr
38.8%
₹201 Cr
Investing CF
₹-586 Cr
98.0%
₹-296 Cr
26.7%
₹-404 Cr
58.0%
₹-962 Cr
48200.0%
₹2 Cr
100.9%
₹-231 Cr
1062.5%
₹24 Cr
185.7%
₹-28 Cr
33.3%
₹-21 Cr
53.3%
₹-45 Cr
Financing CF
₹-123 Cr
78.8%
₹-580 Cr
50.6%
₹-385 Cr
207.8%
₹357 Cr
358.7%
₹-138 Cr
58.6%
₹-87 Cr
71.6%
₹-306 Cr
96.2%
₹-156 Cr
160.0%
₹-60 Cr
67.4%
₹-184 Cr
Net Cash Flow
₹-5 Cr
118.5%
₹27 Cr
145.5%
₹11 Cr
45.0%
₹20 Cr
41.2%
₹34 Cr
1233.3%
₹-3 Cr
50.0%
₹-6 Cr
154.5%
₹11 Cr
74.4%
₹43 Cr
253.6%
₹-28 Cr
Free Cash Flow
₹623 Cr
20.4%
₹783 Cr
45.0%
₹540 Cr
491.3%
₹-138 Cr
73.9%
₹-529 Cr
267.9%
₹315 Cr
53.7%
₹205 Cr
34.0%
₹153 Cr
62.8%
₹94 Cr
95.8%
₹48 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Debtor Days
69d
9.2%
76d
5.6%
72d
7.5%
67d
20.2%
84d
20.0%
70d
1.4%
71d
4.4%
68d
12.8%
78d
8.3%
72d
Inventory Days
192d
30.6%
147d
5.2%
155d
15.7%
134d
24.7%
178d
1.7%
181d
13.8%
159d
6.7%
149d
2.8%
145d
5.1%
138d
Days Payable
110d
3.5%
114d
3.6%
110d
46.7%
75d
22.7%
97d
0.0%
97d
0.0%
97d
34.7%
72d
4.0%
75d
10.3%
68d
Cash Conv. Cycle
151d
38.5%
109d
6.8%
117d
7.9%
127d
22.6%
164d
7.2%
153d
15.0%
133d
8.9%
146d
1.4%
148d
4.2%
142d
Working Capital Days
126d
59.5%
79d
43.6%
55d
32.1%
81d
33.6%
122d
34.1%
91d
12.3%
81d
11.0%
91d
2.2%
93d
24.0%
75d
ROCE
25.0%
3.8%
26.0%
4.0%
25.0%
13.6%
22.0%
4.3%
23.0%
30.3%
33.0%
43.5%
23.0%
27.8%
18.0%
63.6%
11.0%
21.4%
14.0%

Source: Screener.in · Lower days = better efficiency

About JB Chemicals & Pharmaceuticals Limited

J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally. [1]

HealthcarePharmaceuticals & Biotechnology

Related Analysis

Same Sector

ALKEMAlkem Laboratories LimitedNeutralAPOLLOHOSPApollo Hospitals Enterprise LimitedNeutralAUROPHARMAAurobindo Pharma LimitedNeutralBIOCONBiocon LimitedNeutralCIPLACipla LimitedNeutral

Frequently Asked Questions

What is JB Chemicals & Pharmaceuticals Limited share price today?
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) is currently trading at ₹2,416.1 on NSE, up 0.30% as of the last market session. Prices update daily after market close on MarketNetra.
Is JB Chemicals & Pharmaceuticals Limited available in F&O (Futures & Options)?
Yes, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is JB Chemicals & Pharmaceuticals Limited 52-week high and low?
JB Chemicals & Pharmaceuticals Limited's 52-week high is ₹2,526 and the 52-week low is ₹1,603. The current price of ₹2,416.1 is 4.4% below the 52W high.
What is JB Chemicals & Pharmaceuticals Limited P/E ratio?
JB Chemicals & Pharmaceuticals Limited's current P/E ratio is 53.8. This indicates the market is paying ₹53.8 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade JB Chemicals & Pharmaceuticals Limited options?
JB Chemicals & Pharmaceuticals Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade JBCHEPHARM options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.